Inactive Instrument
NicOx SA Share Price Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 24.81M 27.84M 22.69M 20.67M 38.95M 2.63B 40M 273M 109M 1.39B 104M 102M 4.4B | P/E 2026 * |
-5.63x | P/E 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 24.81M 27.84M 22.69M 20.67M 38.95M 2.63B 40M 273M 109M 1.39B 104M 102M 4.4B | EV / Sales 2026 * |
8.27x | EV / Sales 2027 * | 2.48x |
| Free-Float |
96.11% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 27/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 31/12/2014 |
Emmet Purtill
PRN | Corporate Officer/Principal | - | 31/12/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 07/04/2024 |
Damian Marron
CHM | Chairman | 64 | 15/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 15/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 27.84M | |
| -1.95% | +0.72% | +49.45% | +132.47% | 1,263B | |
| -0.16% | -0.24% | +47.60% | +80.97% | 665B | |
| -0.00% | +0.74% | +35.14% | +107.46% | 521B | |
| -1.06% | -2.49% | +47.76% | +65.17% | 387B | |
| -0.66% | +1.98% | +76.83% | +43.02% | 371B | |
| -0.10% | +1.38% | +32.03% | +59.21% | 310B | |
| +0.13% | +7.59% | +12.79% | +36.65% | 293B | |
| -2.00% | +1.23% | +45.81% | +70.95% | 259B | |
| -2.30% | +2.65% | +38.69% | +109.52% | 216B | |
| Average | -1.54% | +5.59% | +42.90% | +78.38% | 476.15B | |
| Weighted average by Cap. | -0.96% | +5.96% | +45.11% | +90.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.37M 2.74M 2.5M 4.71M 318M 4.84M 32.97M 13.18M 168M 12.64M 12.37M 532M | 10M 11.22M 9.15M 8.33M 15.7M 1.06B 16.13M 110M 43.94M 562M 42.12M 41.22M 1.77B |
| Net income | -5M -5.61M -4.57M -4.17M -7.85M -530M -8.06M -54.94M -21.97M -281M -21.06M -20.61M -886M | 2M 2.24M 1.83M 1.67M 3.14M 212M 3.23M 21.98M 8.79M 112M 8.42M 8.24M 354M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
